Exercise Programs for COPD (CLD Trial)

N/A

Recruiting

Led By Shweta Gore, PhD

Research Sponsored by MGH Institute of Health Professions

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be older than 18 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up at 4 months follow up

Awards & highlights

No Placebo-Only Group

Summary

This trial aims to compare the effectiveness of a supervised exercise program delivered either onsite or through telehealth for adults with COPD. The study will evaluate outcomes such as breathlessness, exercise capacity, physical function

Who is the study for?

This trial is for adults with COPD who have completed traditional exercise or physical therapy. They must be able to participate in an 8-week supervised maintenance exercise program either onsite or through telehealth. There's no detailed exclusion criteria provided, but typically those unable to perform exercises or follow the protocol may not qualify.

What is being tested?

The study aims to compare two types of maintenance exercise programs for COPD patients: one conducted onsite and the other via telehealth, against a control group receiving biweekly check-ins without active intervention. The focus is on measuring breathlessness, exercise capacity, physical function, activity levels, and quality of life.

What are the potential side effects?

Since this trial involves exercise programs rather than medication, side effects might include muscle soreness, fatigue from workouts or potential exacerbation of COPD symptoms due to increased activity levels.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ at 4-month follow up

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~at 4-month follow up

This trial's timeline: 3 weeks for screening, Varies for treatment, and at 4-month follow up for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.

Primary study objectives

Dyspnea

Exercise Capacity

Physical Function

+1 more

Secondary study objectives

Adverse events

Healthcare utilization

Inspiratory muscle strength

+3 more

Awards & Highlights

No Placebo-Only Group

All patients enrolled in this study will receive some form of active treatment.

Trial Design

3Treatment groups

Experimental Treatment

Active Control

Group I: Telehealth Pulmonary RehabExperimental Treatment1 Intervention

Supervised pulmonary rehabilitation including exercise training, activity counselling, and education provided remotely using Zoom videoconferencing technology.

Group II: Onsite Pulmonary RehabExperimental Treatment1 Intervention

Supervised pulmonary rehabilitation including exercise training, activity counselling, and education provided onsite.

Group III: ControlActive Control1 Intervention

Control group participants will only be seen during the outcomes assessments at the MGH Institute of Health Professions at times 0, 1, and 2, but will receive no active supervised intervention. Control group participants will go home with discharge instructions to maintain a home exercise routine provided to them at discharge. Bi-weekly check in phone calls from the study team will continue to ensure participant engagement in the study. During the phone calls, participants will be encouraged to keep a log of their weekly activities in a journal.

Do I qualify?Apply below to find out